Embassy of India
Khartoum
26th April, 2020
PRESS RELEASE
In the wake of spread of COVID–19, export of certain medicines and APIs including Paracetamol and Hydroxychloroquine manufactured in India, was put on hold by Government of India. However, following requests received from various foreign Missions based in India requesting exemption of export of Paracetamol and such other medicines on commercial basis, nearly 4000 plus requests from 63 countries/regions are being cleared by Government of India. These requests also include supply of 72000 Paracetamol bottles to Sudan by M/s Amanta Healthcare Limited. This decision has been taken by Government of India on a humanitarian basis, despite enhanced domestic requirements to ensure international supply of this medicine which is widely used, including in cases with Covid-19 and assist the global efforts to combat the Covid-19 pandemic. It is also a symbol of India’s solidarity towards all the countries that require this medicine during the hour of need.